Overview

Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma

Status:
RECRUITING

Trial end date:
2027-02-25

Target enrollment:

Participant gender:

Summary

In this phase 2 study, the investigators aim to evaluate the efficacy and safety of combined therapy using gemcitabine and cisplatin chemotherapy, Lenvatinib and Adebrelimab for patients with advanced and unresectable intrahepatic cholangiocarcinoma

Phase:

PHASE2

Details

Lead Sponsor:

Nanfang Hospital, Southern Medical University

Treatments:

lenvatinib